首页|期刊导航|实用临床医药杂志|5-氨基酮戊酸光动力疗法联合人干扰素α-2β治疗尖锐湿疣的效果分析

5-氨基酮戊酸光动力疗法联合人干扰素α-2β治疗尖锐湿疣的效果分析OACSTPCD

Efficacy of 5-Aminolaevulinic acid photodynamic therapy combined with human interferon α-2β in the treatment of condyloma acuminatum

中文摘要英文摘要

目的 探讨5-氨基酮戊酸光动力疗法(ALA-PDT)联合人干扰素α-2β治疗尖锐湿疣(CA)的效果及对血清T细胞亚群和趋化因子配体19(CCL19)、基质金属蛋白酶-3(MMP-3)水平的影响.方法 选择86例CA患者为研究对象,根据随机数字表法将CA患者分为对照组(ALA-PDT治疗)和观察组(ALA-PDT联合人干扰素α-2β治疗),每组43例.比较2组患者临床疗效以及治疗前后血清T细胞亚群、CCL19、MMP-3水平变化情况,并记录治疗期间不良反应发生情况.随访6个月,记录复发疣体数量和复发率.结果 观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05);治疗后,观察组CD4+、CD8+、CD4+/CD8+较对照组升高,差异有统计学意义(P<0.05).与对照组比较,观察组治疗后血清CCL19升高,MMP-3下降,差异有统计学意义(P<0.05).2组不良反应发生率比较,差异无统计学意义(P>0.05).对照组复发率、平均复发疣体数量高于观察组,差异有统计学意义(P<0.05).结论 ALA-PDT联合人干扰素α-2β治疗尖锐湿疣效果显著,可调节血清T细胞亚群水平,降低MMP-3水平,提升CCL19水平,且安全性较好.

Objective To investigate the therapeutic effects of 5-Aminolaevulinic acid photody-namic therapy(ALA-PDT)combined with human interferon α-2β in the treatment of condyloma acu-minatum(CA)and its impacts on serum T-cell subsets,chemokine ligand 19(CCL19),and matrix metalloproteinase-3(MMP-3)levels.Methods A total of 86 patients with CA were enrolled and ran-domly divided to control group(treated with ALA-PDT alone)and observation group(treated with ALA-PDT combined with human interferon α-2β),with 43 patients in each group.Clinical efficacy,changes in serum T-cell subsets,CCL19,and MMP-3 levels before and after treatment were compared between the two groups.Adverse reactions during treatment were recorded.Patients were followed up for 6 months to record the number of warts and recurrence rate.Results The total effective rate of treatment in the observation group was significantly higher than that in the control group(P<0.05).After treatment,the levels of CD4+,CD8+,and CD4+/CD8+in the observation group were signifi-cantly elevated compared to the control group(P<0.05).Additionally,serum CCL19 levels in-creased,while MMP-3 levels decreased in the observation group post-treatment compared to the control group(P<0.05).No significant difference was observed in the incidence of adverse reactions be-tween the two groups(P>0.05).The recurrence rate and the number of average recurrent warts were significantly higher in the control group than in the observation group(P<0.05).Conclusion The combination of ALA-PDT and human interferon α-2 β exhibits remarkable efficacy in the treatment of CA,which can effectively regulate serum T-cell subset levels,reduce MMP-3 levels,enhance CCL19 levels,and demonstrates good safety.

方宇辉;王馨依;李坤鹏;王伟

安徽省阜阳市人民医院皮肤科,安徽阜阳,236000

临床医学

5-氨基酮戊酸光动力疗法人干扰素α-2β尖锐湿疣趋化因子配体19基质金属蛋白酶-3

5-Aminolevulinic acid photodynamic therapyhuman interferon α-2βcondylo-ma acuminatumchemokine ligand 19matrix metalloproteinase-3

《实用临床医药杂志》 2024 (020)

27-31 / 5

安徽省重点研发计划项目(2022SF-0162)

10.7619/jcmp.20241855

评论